The use of synthetic data for training computer vision algorithms has become increasingly popular due to its cost-effectiveness, scalability, and ability to provide accurate multi-modality labels. Although recent studies have demonstrated impressive results when training networks solely on synthetic data, there remains a performance gap between synthetic and real data that is commonly attributed to lack of photorealism. The aim of this study is to investigate the gap in greater detail for the face parsing task. We differentiate between three types of gaps: distribution gap, label gap, and photorealism gap. Our findings show that the distribution gap is the largest contributor to the performance gap, accounting for over 50% of the gap. By addressing this gap and accounting for the labels gap, we demonstrate that a model trained on synthetic data achieves comparable results to one trained on a similar amount of real data. This suggests that synthetic data is a viable alternative to real data, especially when real data is limited or difficult to obtain. Our study highlights the importance of content diversity in synthetic datasets and challenges the notion that the photorealism gap is the most critical factor affecting the performance of computer vision models trained on synthetic data.

Although machine learning (ML) has shown promise in numerous domains, there are concerns about generalizability to out-of-sample data. This is currently addressed by centrally sharing ample, and importantly diverse, data from multiple sites. However, such centralization is challenging to scale (or even not feasible) due to various limitations. Federated ML (FL) provides an alternative to train accurate and generalizable ML models, by only sharing numerical model updates. Here we present findings from the largest FL study to-date, involving data from 71 healthcare institutions across 6 continents, to generate an automatic tumor boundary detector for the rare disease of glioblastoma, utilizing the largest dataset of such patients ever used in the literature (25, 256 MRI scans from 6, 314 patients). We demonstrate a 33% improvement over a publicly trained model to delineate the surgically targetable tumor, and 23% improvement over the tumor's entire extent. We anticipate our study to: 1) enable more studies in healthcare informed by large and diverse data, ensuring meaningful results for rare diseases and underrepresented populations, 2) facilitate further quantitative analyses for glioblastoma via performance optimization of our consensus model for eventual public release, and 3) demonstrate the effectiveness of FL at such scale and task complexity as a paradigm shift for multi-site collaborations, alleviating the need for data sharing.